tiprankstipranks
Safe Orthopaedics SA (FR:ALSAF)
PARIS:ALSAF
Holding FR:ALSAF?
Track your performance easily

Safe Orthopaedics (ALSAF) Income Statement

0 Followers

Safe Orthopaedics Income Statement

Last quarter (Q ), Safe Orthopaedics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Safe Orthopaedics's net income was $―. See Safe Orthopaedics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 284.40M--$ -1.30M-
Cost of Revenue
-$ 165.00M$ 94.54M$ 86.49M$ 77.96M$ 77.49M
Gross Profit
-$ 119.41M$ -94.54M$ -86.49M$ -77.96M$ -77.49M
Operating Expense
-$ 25.63M$ -80.21M$ -72.05M$ -70.09M$ -68.57M
Operating Income
-$ 91.29M$ 182.64M$ 169.47M$ 8.75M$ 42.27M
Net Non Operating Interest Income Expense
-$ 25.45M$ -16.36M$ -14.65M$ -21.93M$ -25.26M
Other Income Expense
-$ 9.03M$ -7.37M$ -20.44M$ 641.00K$ 898.00K
Pretax Income
-$ 77.35M$ 172.55M$ 174.35M$ -12.90M$ 16.04M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-$ 69.35M$ 163.58M$ 163.56M$ -25.31M$ 4.34M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-$ 190.63M$ 14.33M$ 14.44M$ 7.88M$ 8.92M
Interest Expense
------
Net Income From Continuing And Discontinued Operation
-$ 77.35M$ 172.55M$ 174.35M$ -12.90M$ 16.04M
Normalized Income
-$ 46.48M----
Ebit
-$ 102.06M$ 172.04M$ 189.07M$ -13.09M$ 15.92M
Ebitda
-$ 158.67M$ 223.57M$ 244.33M$ 42.91M$ 68.08M
Currency in USD

Safe Orthopaedics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis